Literature DB >> 16251947

Protein glycosylation: chaperone mutation in Tn syndrome.

Tongzhong Ju1, Richard D Cummings.   

Abstract

Tn syndrome is a rare autoimmune disease in which subpopulations of blood cells in all lineages carry an incompletely glycosylated membrane glycoprotein, known as the Tn antigen. This truncated antigen has the sugar N-acetylgalactosamine alpha-linked to either a serine or threonine amino-acid residue, whereas the correct T antigen has an additional terminal galactose; the defect may be due to a malfunction of the glycosylating enzyme T-synthase. Here we show that Tn syndrome is associated with a somatic mutation in Cosmc, a gene on the X chromosome that encodes a molecular 'chaperone' that is required for the proper folding and hence full activity of T-synthase. The production of the autoimmune Tn antigen by a glycosyltransferase enzyme rendered defective by a disabled chaperone may have implications for other Tn-related disorders such as IgA nephropathy, a condition that can result in renal failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251947     DOI: 10.1038/4371252a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  118 in total

1.  Tight complex formation between Cosmc chaperone and its specific client non-native T-synthase leads to enzyme activity and client-driven dissociation.

Authors:  Rajindra P Aryal; Tongzhong Ju; Richard D Cummings
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

2.  Cosmc is an essential chaperone for correct protein O-glycosylation.

Authors:  Yingchun Wang; Tongzhong Ju; Xiaokun Ding; Baoyun Xia; Wenyi Wang; Lijun Xia; Miao He; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

3.  An O-glycosyltransferase promotes cell adhesion during development by influencing secretion of an extracellular matrix integrin ligand.

Authors:  Liping Zhang; Duy T Tran; Kelly G Ten Hagen
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

4.  Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).

Authors:  Catharina Steentoft; Katrine T Schjoldager; Emiliano Cló; Ulla Mandel; Steven B Levery; Johannes W Pedersen; Knud Jensen; Ola Blixt; Henrik Clausen
Journal:  Glycoconj J       Date:  2010-08-19       Impact factor: 2.916

5.  O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components.

Authors:  E Tian; Matthew P Hoffman; Kelly G Ten Hagen
Journal:  Nat Commun       Date:  2012-05-29       Impact factor: 14.919

Review 6.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

7.  Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.

Authors:  Rongjuan Mi; Lina Song; Yingchun Wang; Xiaokun Ding; Junwei Zeng; Sylvain Lehoux; Rajindra P Aryal; Jianmei Wang; Vanja K Crew; Irma van Die; Arlene B Chapman; Richard D Cummings; Tongzhong Ju
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

Review 8.  The tumour glyco-code as a novel immune checkpoint for immunotherapy.

Authors:  Ernesto RodrÍguez; Sjoerd T T Schetters; Yvette van Kooyk
Journal:  Nat Rev Immunol       Date:  2018-02-05       Impact factor: 53.106

9.  Systematic determination of the peptide acceptor preferences for the human UDP-Gal:glycoprotein-alpha-GalNAc beta 3 galactosyltransferase (T-synthase).

Authors:  Cynthia Perrine; Tongzhong Ju; Richard D Cummings; Thomas A Gerken
Journal:  Glycobiology       Date:  2008-12-10       Impact factor: 4.313

Review 10.  Solid-phase glycan isolation for glycomics analysis.

Authors:  Shuang Yang; Hui Zhang
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.